ArQule, Inc.

We are pursuing a number of exciting and innovative approaches to cancer therapy at ArQule. These are the result of unique biology and world-class chemistry capabilities that differentiate us from other development-stage oncology companies. We are also moving rapidly from innovation to practice. Our lead products are in the clinic, and we expect to generate additional clinical candidates this year and beyond, supported by a strong commitment to discovery research. Our goal is to address major unmet medical needs in oncology. Advances have been made in detection, treatment and prevention in recent years, but for many patients, treatments are still not effective or are significantly toxic. The medical community is benefiting from novel ideas about how to target cancer cells more selectively and with less risk to healthy cells, and ArQule is making a unique contribution to research in this area. Whether you are a clinician, patient, investor, potential collaborator, physician, employee candidate or interested individual, we encourage you to explore our web site and to learn more about our efforts and our growing presence in oncology.